Click here to get full coverage on Precision Biosciences Stock Price Forecast. Should You Buy DTIL? - StockInvest.us

Precision Biosciences Stock Price Forecast. Should You Buy DTIL?  StockInvest.us

Precision Biosciences Stock Price Forecast. Should You Buy DTIL? - StockInvest.us

Click here to get full coverage on DTIL - Finviz

DTIL - Finviz

Click here to get full coverage on Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL) - Seeking Alpha

Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL)  Seeking Alpha

Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL) - Seeking Alpha

Click here to get full coverage on Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength? - Yahoo Finance

Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?  Yahoo Finance

Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength? - Yahoo Finance

Click here to get full coverage on Behavioral Patterns of DTIL and Institutional Flows - Stock Traders Daily

Behavioral Patterns of DTIL and Institutional Flows  Stock Traders Daily

Behavioral Patterns of DTIL and Institutional Flows - Stock Traders Daily

Click here to get full coverage on Precision BioSciences (DTIL) draws 1.1M-share Weinstein stake - Stock Titan

Precision BioSciences (DTIL) draws 1.1M-share Weinstein stake  Stock Titan

Precision BioSciences (DTIL) draws 1.1M-share Weinstein stake - Stock Titan

Click here to get full coverage on Analysts Have Lowered Expectations For Precision BioSciences, Inc. (NASDAQ:DTIL) After Its Latest Results - simplywall.st

Analysts Have Lowered Expectations For Precision BioSciences, Inc. (NASDAQ:DTIL) After Its Latest Results  simplywall.st

Analysts Have Lowered Expectations For Precision BioSciences, Inc. (NASDAQ:DTIL) After Its Latest Results - simplywall.st

Click here to get full coverage on $DTIL stock is up 11% today. Here's what we see in our data. - Quiver Quantitative

$DTIL stock is up 11% today. Here's what we see in our data.  Quiver Quantitative

$DTIL stock is up 11% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Enterprise value to revenue forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView

Enterprise value to revenue forward of Precision BioSciences, Inc. – NASDAQ:DTIL  TradingView

Enterprise value to revenue forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView

Click here to get full coverage on DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus

DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60  GuruFocus

DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus

Click here to get full coverage on Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL) - Benzinga

Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL)  Benzinga

Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL) - Benzinga

Click here to get full coverage on Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire

Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026  Business Wire

Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire

Click here to get full coverage on Should You Buy Precision BioSciences (DTIL) After Golden Cross? - Yahoo Finance

Should You Buy Precision BioSciences (DTIL) After Golden Cross?  Yahoo Finance

Should You Buy Precision BioSciences (DTIL) After Golden Cross? - Yahoo Finance

Click here to get full coverage on Revenue Downgrade: Here's What Analysts Forecast For Precision BioSciences, Inc. (NASDAQ:DTIL) - simplywall.st

Revenue Downgrade: Here's What Analysts Forecast For Precision BioSciences, Inc. (NASDAQ:DTIL)  simplywall.st

Revenue Downgrade: Here's What Analysts Forecast For Precision BioSciences, Inc. (NASDAQ:DTIL) - simplywall.st

Click here to get full coverage on In one patient, gene editor cut hepatitis B cccDNA below 1% - Stock Titan

In one patient, gene editor cut hepatitis B cccDNA below 1%  Stock Titan

In one patient, gene editor cut hepatitis B cccDNA below 1% - Stock Titan

Click here to get full coverage on Trading the Move, Not the Narrative: (DTIL) Edition - Stock Traders Daily

Trading the Move, Not the Narrative: (DTIL) Edition  Stock Traders Daily

Trading the Move, Not the Narrative: (DTIL) Edition - Stock Traders Daily

Click here to get full coverage on Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire

Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update  Business Wire

Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire

Click here to get full coverage on Lynx1 Capital discloses 5.4% Precision BioSciences (DTIL) ownership in Schedule 13G - Stock Titan

Lynx1 Capital discloses 5.4% Precision BioSciences (DTIL) ownership in Schedule 13G  Stock Titan

Lynx1 Capital discloses 5.4% Precision BioSciences (DTIL) ownership in Schedule 13G - Stock Titan

Click here to get full coverage on Index Expanding Market Visibility with Institutional Investors - Business Wire

Index Expanding Market Visibility with Institutional Investors  Business Wire

Index Expanding Market Visibility with Institutional Investors - Business Wire

Click here to get full coverage on Empery Asset Management (DTIL) caps Precision BioSciences stake at 4.99% with warrant blocker - Stock Titan

Empery Asset Management (DTIL) caps Precision BioSciences stake at 4.99% with warrant blocker  Stock Titan

Empery Asset Management (DTIL) caps Precision BioSciences stake at 4.99% with warrant blocker - Stock Titan

Click here to get full coverage on Digital twin tech could simplify nuclear decommissioning robotics - The Engineer

Digital twin tech could simplify nuclear decommissioning robotics  The Engineer

Digital twin tech could simplify nuclear decommissioning robotics - The Engineer

Click here to get full coverage on Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study - Business Wire

Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study  Business Wire

Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study - Business Wire

Click here to get full coverage on Precision BioSciences 1Q 2026: Revenue $10.8M, EPS $(0.75) — 10-Q Summary - TradingView

Precision BioSciences 1Q 2026: Revenue $10.8M, EPS $(0.75) — 10-Q Summary  TradingView

Precision BioSciences 1Q 2026: Revenue $10.8M, EPS $(0.75) — 10-Q Summary - TradingView

Click here to get full coverage on Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL)  Seeking Alpha

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha

Click here to get full coverage on Precision BioSciences stock jumps on hepatitis B trial data - Investing.com

Precision BioSciences stock jumps on hepatitis B trial data  Investing.com

Precision BioSciences stock jumps on hepatitis B trial data - Investing.com

Click here to get full coverage on Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting - Business Wire

Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting  Business Wire

Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting - Business Wire

Click here to get full coverage on Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones - Business Wire

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones  Business Wire

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones - Business Wire

Click here to get full coverage on Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries - Business Wire

Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries  Business Wire

Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries - Business Wire

Click here to get full coverage on Precision BioSciences (DTIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Focuses on Pipeline - vinanet.vn

Precision BioSciences (DTIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Focuses on Pipeline  vinanet.vn

Precision BioSciences (DTIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Focuses on Pipeline - vinanet.vn

Click here to get full coverage on Precision BioSciences (DTIL) Rises 1.78% as Gene-Editing Stock Holds Firm Above Support - Growth Stock Picks - vinanet.vn

Precision BioSciences (DTIL) Rises 1.78% as Gene-Editing Stock Holds Firm Above Support - Growth Stock Picks  vinanet.vn

Precision BioSciences (DTIL) Rises 1.78% as Gene-Editing Stock Holds Firm Above Support - Growth Stock Picks - vinanet.vn

Click here to get full coverage on Precision BioSciences Inc (DTIL) Institutional Confidence - TradingKey

Precision BioSciences Inc (DTIL) Institutional Confidence  TradingKey

Precision BioSciences Inc (DTIL) Institutional Confidence - TradingKey

Click here to get full coverage on Precision BioSciences (DTIL) Advances 1.78% as Gene-Editing Speculation Builds - Bear Flag - vinanet.vn

Precision BioSciences (DTIL) Advances 1.78% as Gene-Editing Speculation Builds - Bear Flag  vinanet.vn

Precision BioSciences (DTIL) Advances 1.78% as Gene-Editing Speculation Builds - Bear Flag - vinanet.vn

Click here to get full coverage on Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants - Latham & Watkins LLP

Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants  Latham & Watkins LLP

Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants - Latham & Watkins LLP

Click here to get full coverage on Precision BioSciences (DTIL) Faces Significant Decline, Testing Key Support Levels - EMA Signal - dars.gov.et

Precision BioSciences (DTIL) Faces Significant Decline, Testing Key Support Levels - EMA Signal  dars.gov.et

Precision BioSciences (DTIL) Faces Significant Decline, Testing Key Support Levels - EMA Signal - dars.gov.et

Click here to get full coverage on Precision BioSciences (DTIL) Consolidates Near $7 as Gene Editing Sector Awaits Catalysts - Monthly Profile - vinanet.vn

Precision BioSciences (DTIL) Consolidates Near $7 as Gene Editing Sector Awaits Catalysts - Monthly Profile  vinanet.vn

Precision BioSciences (DTIL) Consolidates Near $7 as Gene Editing Sector Awaits Catalysts - Monthly Profile - vinanet.vn

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Precision (DTIL) Momentum: Rises 1.61% to $8.86 in the Current Update; Chart View: the $8.42 to $9.30 Range Remains in Focus for the Current Session - Retracement Entry - vinanet.vn

Precision (DTIL) Momentum: Rises 1.61% to $8.86 in the Current Update; Chart View: the $8.42 to $9.30 Range Remains in Focus for the Current Session - Retracement Entry  vinanet.vn

Precision (DTIL) Momentum: Rises 1.61% to $8.86 in the Current Update; Chart View: the $8.42 to $9.30 Range Remains in Focus for the Current Session - Retracement Entry - vinanet.vn

Click here to get full coverage on DTIL Q2 2026 Earnings: Wider-than-Expected Loss Highlights Clinical-Stage Biotech Challenges - GAAP Earnings Report - vinanet.vn

DTIL Q2 2026 Earnings: Wider-than-Expected Loss Highlights Clinical-Stage Biotech Challenges - GAAP Earnings Report  vinanet.vn

DTIL Q2 2026 Earnings: Wider-than-Expected Loss Highlights Clinical-Stage Biotech Challenges - GAAP Earnings Report - vinanet.vn

Click here to get full coverage on DTIL Q2 2026 Earnings: Wider-than-Expected Loss Pressures Shares - Banking Earnings Report - vinanet.vn

DTIL Q2 2026 Earnings: Wider-than-Expected Loss Pressures Shares - Banking Earnings Report  vinanet.vn

DTIL Q2 2026 Earnings: Wider-than-Expected Loss Pressures Shares - Banking Earnings Report - vinanet.vn

Click here to get full coverage on Precision BioSciences (DTIL) Climbs 3.12% to $7.28 as Gene-Editing Support Holds - Regression Channel - vinanet.vn

Precision BioSciences (DTIL) Climbs 3.12% to $7.28 as Gene-Editing Support Holds - Regression Channel  vinanet.vn

Precision BioSciences (DTIL) Climbs 3.12% to $7.28 as Gene-Editing Support Holds - Regression Channel - vinanet.vn

Click here to get full coverage on Precision BioSciences (DTIL) Holds Steady Near Support as Biotech Sector Watches Key Levels - PSAR Stop - vinanet.vn

Precision BioSciences (DTIL) Holds Steady Near Support as Biotech Sector Watches Key Levels - PSAR Stop  vinanet.vn

Precision BioSciences (DTIL) Holds Steady Near Support as Biotech Sector Watches Key Levels - PSAR Stop - vinanet.vn

Click here to get full coverage on DTIL Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock Movement - Analyst Earnings Estimate - vinanet.vn

DTIL Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock Movement - Analyst Earnings Estimate  vinanet.vn

DTIL Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock Movement - Analyst Earnings Estimate - vinanet.vn

Click here to get full coverage on Precision (DTIL) Range: Posts a 2.59% Gain to $8.72 at the Close; the Current Price Sits Inside the Supplied Technical Range in the Latest Reading - AAII Bullish - dars.gov.et

Precision (DTIL) Range: Posts a 2.59% Gain to $8.72 at the Close; the Current Price Sits Inside the Supplied Technical Range in the Latest Reading - AAII Bullish  dars.gov.et

Precision (DTIL) Range: Posts a 2.59% Gain to $8.72 at the Close; the Current Price Sits Inside the Supplied Technical Range in the Latest Reading - AAII Bullish - dars.gov.et

Click here to get full coverage on Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Protective Put - vinanet.vn

Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Protective Put  vinanet.vn

Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Protective Put - vinanet.vn

Click here to get full coverage on DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss - Consensus Forecast Report - vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss - Consensus Forecast Report  vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss - Consensus Forecast Report - vinanet.vn

Click here to get full coverage on Precision (DTIL) Range: Posts a 2.59% Gain to $8.72 at the Close; the Current Price Sits Inside the Supplied Technical Range in the Latest Reading - Sell Signal Alerts - dars.gov.et

Precision (DTIL) Range: Posts a 2.59% Gain to $8.72 at the Close; the Current Price Sits Inside the Supplied Technical Range in the Latest Reading - Sell Signal Alerts  dars.gov.et

Precision (DTIL) Range: Posts a 2.59% Gain to $8.72 at the Close; the Current Price Sits Inside the Supplied Technical Range in the Latest Reading - Sell Signal Alerts - dars.gov.et

Click here to get full coverage on Precision BioSciences (DTIL) Consolidates Near $7 as Gene Editing Sector Awaits Catalysts - AI Trade Signals - dars.gov.et

Precision BioSciences (DTIL) Consolidates Near $7 as Gene Editing Sector Awaits Catalysts - AI Trade Signals  dars.gov.et

Precision BioSciences (DTIL) Consolidates Near $7 as Gene Editing Sector Awaits Catalysts - AI Trade Signals - dars.gov.et

Click here to get full coverage on Precision BioSciences (DTIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Focuses on Pipeline - dars.gov.et

Precision BioSciences (DTIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Focuses on Pipeline  dars.gov.et

Precision BioSciences (DTIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Focuses on Pipeline - dars.gov.et

Click here to get full coverage on DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss - Guidance Downgrade Alert - vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss - Guidance Downgrade Alert  vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss - Guidance Downgrade Alert - vinanet.vn

Click here to get full coverage on DTIL Q2 2026 Earnings: Revenue Growth Amidst Narrowing Losses - Earnings Season Review - vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Narrowing Losses - Earnings Season Review  vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Narrowing Losses - Earnings Season Review - vinanet.vn

Click here to get full coverage on DTIL Q2 2026 Earnings: Revenue Grows 3.24% YoY but Net Loss Persists - Strong Earnings Momentum - vinanet.vn

DTIL Q2 2026 Earnings: Revenue Grows 3.24% YoY but Net Loss Persists - Strong Earnings Momentum  vinanet.vn

DTIL Q2 2026 Earnings: Revenue Grows 3.24% YoY but Net Loss Persists - Strong Earnings Momentum - vinanet.vn

Click here to get full coverage on Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones - 01net

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones  01net

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones - 01net

Click here to get full coverage on DTIL Q1 2026 Earnings: Wider-than-Expected Loss Highlights Cost Pressures and Pipeline Uncertainty - Dividend Growth Analysis - vinanet.vn

DTIL Q1 2026 Earnings: Wider-than-Expected Loss Highlights Cost Pressures and Pipeline Uncertainty - Dividend Growth Analysis  vinanet.vn

DTIL Q1 2026 Earnings: Wider-than-Expected Loss Highlights Cost Pressures and Pipeline Uncertainty - Dividend Growth Analysis - vinanet.vn

Click here to get full coverage on DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Free Cash Flow Trends - vinanet.vn

DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Free Cash Flow Trends  vinanet.vn

DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Free Cash Flow Trends - vinanet.vn

Click here to get full coverage on Precision BioSciences announces leadership changes - Investing.com

Precision BioSciences announces leadership changes  Investing.com

Precision BioSciences announces leadership changes - Investing.com

Click here to get full coverage on Precision BioSciences added to Russell 2000 index - Investing.com

Precision BioSciences added to Russell 2000 index  Investing.com

Precision BioSciences added to Russell 2000 index - Investing.com

Click here to get full coverage on DTIL Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Pipeline - Tax Rate Impact - dars.gov.et

DTIL Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Pipeline - Tax Rate Impact  dars.gov.et

DTIL Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Pipeline - Tax Rate Impact - dars.gov.et

Click here to get full coverage on Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Advance Decline Volume - dars.gov.et

Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Advance Decline Volume  dars.gov.et

Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Advance Decline Volume - dars.gov.et

Click here to get full coverage on Dhunseri Tea & Industries (DTIL.NS) Declines 1.78% as Stock Teaches Key Support Levels - KAMA Signal - vinanet.vn

Dhunseri Tea & Industries (DTIL.NS) Declines 1.78% as Stock Teaches Key Support Levels - KAMA Signal  vinanet.vn

Dhunseri Tea & Industries (DTIL.NS) Declines 1.78% as Stock Teaches Key Support Levels - KAMA Signal - vinanet.vn

Click here to get full coverage on DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss, Market Reacts Positively - One-Time Loss Impact - vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss, Market Reacts Positively - One-Time Loss Impact  vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Net Loss, Market Reacts Positively - One-Time Loss Impact - vinanet.vn

Click here to get full coverage on DTIL Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock Movement - Earnings Power Value - dars.gov.et

DTIL Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock Movement - Earnings Power Value  dars.gov.et

DTIL Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock Movement - Earnings Power Value - dars.gov.et

Click here to get full coverage on DTIL Q2 2026 Earnings: Revenue Growth Amidst Continued Losses - One-Time Gain Impact - vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Continued Losses - One-Time Gain Impact  vinanet.vn

DTIL Q2 2026 Earnings: Revenue Growth Amidst Continued Losses - One-Time Gain Impact - vinanet.vn

Click here to get full coverage on DTIL Q2 FY2026 Earnings: Revenue edges up but EPS turns negative amid margin pressures - Estimate Dispersion - vinanet.vn

DTIL Q2 FY2026 Earnings: Revenue edges up but EPS turns negative amid margin pressures - Estimate Dispersion  vinanet.vn

DTIL Q2 FY2026 Earnings: Revenue edges up but EPS turns negative amid margin pressures - Estimate Dispersion - vinanet.vn

Click here to get full coverage on DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Earnings Surprise Report - dars.gov.et

DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Earnings Surprise Report  dars.gov.et

DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Earnings Surprise Report - dars.gov.et

Click here to get full coverage on DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Forward Guidance Trends - dars.gov.et

DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Forward Guidance Trends  dars.gov.et

DTIL Q1 2026 Earnings: EPS Misses Estimates as Stock Declines - Forward Guidance Trends - dars.gov.et

Click here to get full coverage on Dhunseri Tea & Industries (DTIL.NS) Declines 3.94%: Stock Holds Above Key Support at ₹158.74 - Retracement Entry - siam.in

Dhunseri Tea & Industries (DTIL.NS) Declines 3.94%: Stock Holds Above Key Support at ₹158.74 - Retracement Entry  siam.in

Dhunseri Tea & Industries (DTIL.NS) Declines 3.94%: Stock Holds Above Key Support at ₹158.74 - Retracement Entry - siam.in

Click here to get full coverage on Precision BioSciences stock gains as market cap tops 200 million USD - ad-hoc-news.de

Precision BioSciences stock gains as market cap tops 200 million USD  ad-hoc-news.de

DTIL

Price Chart

Key Statistics

Technicals

About DTIL

Latest News

Precision Biosciences Stock Price Forecast. Should You Buy DTIL? - StockInvest.us

DTIL - Finviz

Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL) - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers